Details for New Drug Application (NDA): 210227
✉ Email this page to a colleague
The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 210227
Tradename: | MEDROXYPROGESTERONE ACETATE |
Applicant: | Xiromed |
Ingredient: | medroxyprogesterone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 210227
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 210227 | ANDA | Mylan Institutional LLC | 67457-887 | 67457-887-01 | 25 VIAL in 1 CARTON (67457-887-01) / 1 mL in 1 VIAL (67457-887-00) |
MEDROXYPROGESTERONE ACETATE | medroxyprogesterone acetate | INJECTABLE;INJECTION | 210227 | ANDA | Mylan Institutional LLC | 67457-887 | 67457-887-99 | 1 VIAL in 1 CARTON (67457-887-99) / 1 mL in 1 VIAL (67457-887-00) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/ML | ||||
Approval Date: | Oct 12, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription